StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines total Lease Cost ($M) ($M)

Form 10-K Leases Note (XBRL)

Latest, FY2025
31
Period ended Dec 31, 2025
Change on a year earlier
-8.8%
34 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Lease Cost ($M) ($M)Year on yearSource
FY2025Dec 31, 202531-8.8%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202434+0.6%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202333.8-0.9%Form 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 202234.1+16.8%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 202129.2+33.9%Form 10-K (filed 2024-02-26) ↗
FY2020Dec 31, 202021.8+29.8%Form 10-K (filed 2023-02-27) ↗
FY2019Dec 31, 201916.8–Form 10-K (filed 2022-02-28) ↗

Breakdown

What makes up total lease cost ($m)

Cite this data

StockData. (2026). BeOne Medicines Total Lease Cost ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/tot_lease_cost

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.